The latest gluten-free news: celiac diagnosis and testing, new Polish guidelines, diabetes research, biopsy findings and gluten and allergen recalls.
The latest gluten-free news: regulatory updates, celiac disease research, expanded adult care, and recalls in the U.S., Canada and Spain.
Celiac drug trial results, updated prevalence data, a Brazilian labeling case, school guidance, and recalls — the latest in gluten-free research and policy.
A Cleveland Clinic AI model reaches 97% accuracy distinguishing celiac from normal biopsies, while a Norwegian study finds evidence of historical misdiagnosis. Plus long-term outcomes, COVID-19 risk and recalls.
Spain funds gluten-free diets, Sydney Airport’s labeling faces scrutiny, and four bills advance in Congress. Plus a drug acquisition and product recalls.
Tunisia funds gluten-free diets, Codex sets a global “may contain” gluten standard, and the UK updates celiac diagnosis guidance. Plus recalls.
The latest gluten-free news from around the world: a New Zealand hospital case, new celiac disease research from Norway, advocacy stories from Malta and Spain, and recent gluten-related recalls in the UK and France.
How Catholic, Orthodox, and Jewish traditions navigate gluten-free needs in communion, matzo, and ritual food — and where the conflicts remain unresolved.
Gluten and faith: an unresolved conflict Read More »
June’s gluten-free news: FDA’s labeling review, Virginia’s takeout law, beer testing gaps, a probiotic yeast study, and recalls in three countries.
Celiac disease raises the risk of death, heart disease, and organ failure — and two new studies published this week put the numbers on paper for the first time in the U.S. This edition also covers a landmark labeling bill, a stalled compensation law in Spain, and how major league baseball is stepping up for the celiac community.
Celiac Disease, Mortality Risk, and the New Celiac Safety Act | The Gluten-Free Brief Read More »
